Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose psilocybin for alcohol use disorder
2020-000829-55Phase 2Active
- Sponsor
- Psychiatric Centre Copenhagen
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Psilocybin with Placebo (2 arms). Started Oct 2020; status: active.
02
Drugs
psilocybin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2020-000829-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000829-55.